Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 286

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 286
---
 recalculated
the value of the warrants by applying a +/- 5.0% changes to the input variables in PWERM. As of December 31, 2023, a 5.0% decrease in
discount rate would increase the fair value of the warrants to $408; a 5.0% increase in discount rate would decrease the fair value of
the warrants to $397.

| NOTE 8:- | TAXES ON INCOME |

| a. | Tax rates applicable to the Company: |

| b. | Net operating loss carry forward: |

As of December 31, 2023, the Company had
net operating loss carry forwards and capital loss carry forward for Israeli income tax purposes of approximately $39,800 and $117, respectively. Net
operating loss carry forwards in Israel may be carried forward indefinitely and offset against future taxable income.

| d. | Deferred income taxes: |

Deferred income taxes reflect the net
tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts
used for income tax purposes.

<div align='center'>F-35</div>

REGENTIS BIOMATERIALS LTD.

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands, except share and per share data

| NOTE 8:- | TAXES ON INCOME (Cont.) |

Significant components of the Company’s
deferred tax assets are as follows:

| Deferred tax assets:                          |     | December 31, 
 2023         |        |   |     | 2022 |        |   |
|:----------------------------------------------|:----|:-------------|-------:|:--|:----|:-----|-------:|:--|
| Net operating loss carry forward              |     | $            | 40,064 |   |     | $    | 39,803 |   |
| Deferred tax asset before valuation allowance |     |              |  9,214 |   |     |      |  9,155 |   |
| Valuation allowance                           |     |              | (9,214 | ) |     |      | (9,155 | ) |
| Net deferred tax asset                        |     | $            |      - |   |     | $    |      - |   |

In assessing the realization of deferred
tax assets, management considers whether it is more likely than not that all or some portion of the deferred tax assets will not be realized.

The